| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
4,220 |
1,887 |
$119K |
| 80053 |
Comprehensive metabolic panel |
4,325 |
3,414 |
$23K |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
11,504 |
6,892 |
$15K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,935 |
3,566 |
$14K |
| 85027 |
|
4,661 |
3,457 |
$14K |
| G2024 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source |
3,373 |
1,499 |
$12K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,734 |
1,515 |
$11K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,612 |
2,811 |
$10K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
353 |
141 |
$10K |
| P9603 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled |
5,825 |
3,310 |
$7K |
| 80061 |
Lipid panel |
1,460 |
1,374 |
$6K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,138 |
1,962 |
$6K |
| 80164 |
|
345 |
275 |
$5K |
| 87088 |
|
1,443 |
1,257 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
8,164 |
4,296 |
$3K |
| 85610 |
|
1,200 |
245 |
$3K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
249 |
173 |
$2K |
| 87186 |
|
610 |
524 |
$2K |
| 87077 |
|
650 |
541 |
$1K |
| 81001 |
|
1,385 |
1,247 |
$1K |
| 80076 |
|
329 |
308 |
$1K |
| 84439 |
|
340 |
313 |
$540.34 |
| 99001 |
|
381 |
208 |
$264.00 |
| 80177 |
|
26 |
24 |
$262.02 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,647 |
795 |
$250.00 |
| 82565 |
|
43 |
42 |
$203.83 |
| 83735 |
|
73 |
55 |
$123.31 |
| 82607 |
|
16 |
12 |
$62.48 |
| G0471 |
Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) |
6,956 |
4,089 |
$28.74 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
25 |
25 |
$0.00 |
| 87634 |
|
24 |
24 |
$0.00 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
24 |
24 |
$0.00 |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
24 |
24 |
$0.00 |
| 87150 |
|
25 |
25 |
$0.00 |
| 87486 |
|
24 |
24 |
$0.00 |
| 87541 |
|
24 |
24 |
$0.00 |
| 87581 |
|
24 |
24 |
$0.00 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
25 |
25 |
$0.00 |